NCT00158041View on ClinicalTrials.gov

Subcutaneous Amifostine Safety Study

PHASE4CompletedINTERVENTIONAL

Enrollment

452

Participants

Timeline

Start Date

January 31, 2002

Study Completion Date

January 31, 2005

Conditions

Head and Neck CancerLung CancerLymphoma

Interventions

DRUG

Amifostine administered subcutaneously

Trial Locations (1)

33140

Mt. Sinai Medical Center, Miami Beach

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

MedImmune LLC

INDUSTRY

lead

Mt. Sinai Medical Center, Miami

OTHER